A Phase 1 Study of ZN-C3 As a Single Agent In Subjects with Solid Tumors

Disease:

Study phase:

Physician name:

Funda Meric-Bernstam

Department:

Investigational Cancer Therapeutics

For general questions about clinical trials:

1-866-967-2182